Atara Biotherapeutics, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↓-81.5% -$89M
$20M
Current Assets↓-81.2% -$53M
$12M
Cash & Equivalents↓-66.1% -$17M
$8M
ST Investments↓-100.0% -$17M
$0
Receivables↓-15.5% -$229K
$1M
Inventory↓-100.0% -$11M
$0
Net PPE↓-94.4% -$1M
$73K
Total Liabilities↓-71.5% -$148M
$59M
Current Liabilities↓-88.9% -$120M
$15M
Account Payables↓-97.1% -$4M
$127K
Stockholders Equity↑+60.4% +$59M
$-39M
Retained Earnings↑+1.6% +$33M
$-2.02B
Operating Lease ROU Asset↓-82.3% -$33M
$7M
Operating Lease Liability↓-65.3% -$20M
$10M
Gross PP&E↓-98.5% -$18M
$286K
Accumulated Depreciation↓-98.8% -$17M
$213K
Inventory Raw Materials↓-100.0% -$964K
$0
Inventory WIP↓-100.0% -$10M
$0
Contract Liability↓-100.0% -$567K
$0
Contract Liability (Current)
—
Contract Liability (Noncurrent)↓-100.0% -$567K
$0